Browsing Tag
Mesenchymal Stem Cells
2 posts
Is this the biomarker breakthrough Longeveron Inc. needs to reach Phase 3?
Can biomarker-linked response boost laromestrocel’s Phase 3 prospects? Explore regulatory, financial, and industry implications.
Cynata Therapeutics wraps up patient enrollment for diabetic foot ulcers clinical trial
In a significant development for diabetic foot ulcer treatments, Cynata Therapeutics Limited (ASX: CYP), a leading clinical-stage biotechnology…